Skip to content

Effectiveness of Intensive Light Therapy in Severely Jaundiced Sick Premature Babies

Efficacy of Intensive Phototherapy in Pathological Unconjugated Hyperbilirubinemic Unstable Preterm Neonates: A Prospective Observational Study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2021/09/036501
Enrollment
50
Registered
2021-09-14
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E806- Other disorders of bilirubin metabolism

Interventions

None listed

Sponsors

Maulana Azad Medical College
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1) Gestational age more than or equal to 28 to less than 37 weeks, if not ascertainable, then admission weight between more than or equal to 1000 g to less than 2500 g. 2) Neonates with pathologic unconjugated hyperbilirubinemia as per NICE guidelines. 3) Postnatal age 14 days or less.

Exclusion criteria

Exclusion criteria: 1) Neonates who required exchange transfusion prior to and within 24 hours of enrollment. 2) Neonates who have received phototherapy for more than or equal to 6 hours duration prior to enrollment. 3) Neonates with major congenital malformation.

Design outcomes

Primary

MeasureTime frame
Rate of change of total serum bilirubin measured as mg/dl/hour and mg/dl/hour/mg of total serum bilirubin in first 24 ± 4 hours following phototherapy initiation.Timepoint: 15 Days

Secondary

MeasureTime frame
Duration of phototherapyTimepoint: 28 Days;Need for exchange transfusionTimepoint: 28 Days;Occurrence of acute bilirubin encephalopathy by M-BIND score.Timepoint: 28 Days;Rate of change in bilirubin albumin molar ratio (BAMR)Timepoint: 15 Days;Rate of change of total serum bilirubin measured as mg/dl/hour and mg/dl/hour/mg of total serum bilirubin until stoppage of phototherapy.Timepoint: 28 Days;Rebound in serum bilirubin at 12 ± 3 hours of discontinuation of phototherapyTimepoint: 28 Days;To evaluate the acceptability of LED intensive phototherapy by mother and staff nurses in pathological unconjugated hyperbilirubinemic unstable preterm neonates.Timepoint: 28 Days

Countries

India

Contacts

Public ContactDr Lalit Kumar

Maulana Azad Medical College Delhi

ajayneonatology@gmail.com9968604310

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026